Meta-analysis of Valve-in-Valve Transcatheter versus Redo Surgical Aortic Valve Replacement.
CONCLUSION: In patients with degenerated aortic valve bioprostheses, especially elderly or high-risk patients, VIV-TAVI could be a safe, feasible alternative to redo SAVR. The lack of randomized data and differences in baseline characteristics in the present analysis emphasize the need for prospective randomized trials.
PMID: 30114716 [PubMed - as supplied by publisher]
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Takagi H, Mitta S, Ando T Tags: Thorac Cardiovasc Surg Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Coronary Artery Bypass Graft | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Valve Surgery | Statistics | Study | Women